Cargando…
EPEN-21. Developing a sensitive method for detection of minimal residual disease in ependymoma using metabolomic analysis of cerebrospinal fluid
INTRODUCTION: Ependymoma (EPN) is the second most common malignant paediatric brain tumour with poor survival and significant neuro-cognitive impairment from current treatments (surgery and radiotherapy). Relapse occurs in 50% of patients within 2 years, despite no evidence of tumour on MRI. This su...
Autores principales: | Woodward, Alison, Amugi, Laudina, Patel, Kishan, Kilpatrick, Charlotte, Kim, Dong-hyun, Dandapani, Madhumita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165224/ http://dx.doi.org/10.1093/neuonc/noac079.719 |
Ejemplares similares
-
EPEN-01. MULTIDISCIPLINARY TREATMENT IN EPENDYMOMA
por: Hirokawa, Daisuke
Publicado: (2020) -
EPEN-47. PEDS: PEDIATRIC EPENDYMOMA DISCOVERY STUDY
por: Smith, Amy, et al.
Publicado: (2020) -
EPEN-05. Adenosine receptor expression in paediatric ependymoma
por: Spanoudakis, Chelsea, et al.
Publicado: (2022) -
EPEN-16. TRANSCRIPTIONAL REGULATORY CIRCUITRIES AS MOLECULAR TARGETS IN EPENDYMOMA
por: Bertrand, Kelsey, et al.
Publicado: (2020) -
EPEN-24. SIOP EPENDYMOMA II: CENTRAL EPENDYMOMA MANAGEMENT ADVISORY GROUP – THE UK EXPERIENCE
por: Macarthur, Donald C, et al.
Publicado: (2020)